The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in ...
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five ...
The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or ...
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two ...
Following a tumultuous stretch under ex-Commissioner Marty Makary, current FDA leadership is working to restore reliability, ...
Kaos Capital in a letter to other Capricor Therapeutics shareholders called for “an immediate meeting, board change, and ...
Three fatalities occurring recently in China clinical trials have spurred two members of U.S. Congress to urge the FDA to ...
The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a ...
After committing $2 billion to a new North Carolina facility to boost capacity for its next-gen obesity candidates, Roche's ...
Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...
SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery, the AI company building a computer-aided design suite for molecules, today announced a collaboration with Bristol Myers Squibb to advance the discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results